Evaluation of Behaviour in Parkinson's Disease. Normal Values in Healthy Subjects
ECMP
Evaluation Comportementale Dans la Maladie de Parkinson. Normes Chez Des Sujets Sains
1 other identifier
interventional
124
0 countries
N/A
Brief Summary
Non-motor symptoms like mood fluctuations and behavioral disorders are frequent in Parkinson's disease. They may be induced by both the pathology and the dopaminergic treatment and must be considered in treatment policies. Due to their specificity and the absence of an appropriate evaluation tool, behavioral disorders are rarely searched for. Therefore, investigators developed a scale permitting qualitative and quantitative evaluation of behavior according to the severity of the disorders. This study aims to define reference values for healthy individuals
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2009
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2015
CompletedFirst Submitted
Initial submission to the registry
May 25, 2016
CompletedFirst Posted
Study publicly available on registry
July 1, 2016
CompletedJuly 1, 2016
May 1, 2016
6 years
May 25, 2016
June 28, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
ECMP score
Semi-structured interview
3 hours
Study Arms (1)
Healthy participants
OTHERSubmission of the scale 'Evaluation of behaviour in Parkinson's Disease' to healthy subjects
Interventions
Eligibility Criteria
You may qualify if:
- Healthy participants without any neurologic disease
- Men and women from 25 to 75 years old
- French mother tong
- without cognitive troubles (MMS ≥ 24)
You may not qualify if:
- Subject under legal guardianship
- Pregnant woman or with childbearing potential without contraceptive device
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Anna Castrioto, MD
University Hospital, Grenoble
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 25, 2016
First Posted
July 1, 2016
Study Start
April 1, 2009
Primary Completion
April 1, 2015
Study Completion
April 1, 2015
Last Updated
July 1, 2016
Record last verified: 2016-05
Data Sharing
- IPD Sharing
- Will not share